☰

Corbin Bachmeier - Publications

Affiliations: 
2001-2005 Pharmaceutical Sciences University of Nebraska Medical Center, Omaha, NE, United States 
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shackleton B, Crawford F, Bachmeier C. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Fluids and Barriers of the Cns. 13: 14. PMID 27503326 DOI: 10.1186/S12987-016-0038-X  0.345
2013 Bachmeier C, Levin GM, Beaulieu-Abdelahad D, Reed J, Mullan M. Effect of venlafaxine and desvenlafaxine on drug efflux protein expression and biodistribution in vivo. Journal of Pharmaceutical Sciences. 102: 3838-43. PMID 23897419 DOI: 10.1002/Jps.23680  0.618
2013 Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier. Molecular and Cellular Neurosciences. 56: 255-62. PMID 23831388 DOI: 10.1016/J.Mcn.2013.06.004  0.301
2013 On NH, Mitchell R, Savant SD, Bachmeier CJ, Hatch GM, Miller DW. Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model. Journal of Neuro-Oncology. 111: 133-43. PMID 23184143 DOI: 10.1007/s11060-012-1006-1  0.476
2011 Bachmeier CJ, Beaulieu-Abdelahad D, Ganey NJ, Mullan MJ, Levin GM. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine. Biopharmaceutics & Drug Disposition. 32: 233-44. PMID 21446053 DOI: 10.1002/bdd.753  0.65
2010 Bachmeier C, Mullan M, Paris D. Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier. Cytotechnology. 62: 519-29. PMID 20954006 DOI: 10.1007/S10616-010-9313-X  0.365
2007 Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Molecular Pharmaceutics. 4: 730-8. PMID 17705442 DOI: 10.1021/Mp070024D  0.577
2006 Bachmeier CJ, Trickler WJ, Miller DW. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 998-1003. PMID 16554372 DOI: 10.1124/dmd.105.006999  0.617
2005 Bachmeier CJ, Spitzenberger TJ, Elmquist WF, Miller DW. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Pharmaceutical Research. 22: 1259-68. PMID 16078135 DOI: 10.1007/s11095-005-5271-y  0.672
2005 Bachmeier CJ, Miller DW. A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier. Pharmaceutical Research. 22: 113-21. PMID 15771237 DOI: 10.1007/s11095-004-9016-0  0.674
2004 Bachmeier CJ, Trickler WJ, Miller DW. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF. Journal of Pharmaceutical Sciences. 93: 932-42. PMID 14999730 DOI: 10.1002/jps.20018  0.617
2003 Zhang Y, Bachmeier C, Miller DW. In vitro and in vivo models for assessing drug efflux transporter activity. Advanced Drug Delivery Reviews. 55: 31-51. PMID 12535573 DOI: 10.1016/S0169-409X(02)00170-9  0.668
Show low-probability matches.